CCL19 Antikörper (Internal Region)
-
- Target Alle CCL19 Antikörper anzeigen
- CCL19 (Chemokine (C-C Motif) Ligand 19 (CCL19))
-
Bindungsspezifität
- AA 20-100, Internal Region
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CCL19 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Verwendungszweck
- Rabbit polyclonal to MIP-3β.
- Spezifität
- MIP-3β Polyclonal Antibody detects endogenous levels of MIP-3β protein.
- Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogen
- Synthesized peptide derived from human MIP-3beta
- Isotyp
- IgG
- Top Product
- Discover our top product CCL19 Primärantikörper
-
-
- Applikationshinweise
-
IHC 1:100-1:300
ELISA 1:40000 - Kommentare
-
Expressed at high levels in the lymph nodes, thymus and appendix. Intermediate levels seen in colon and trachea, while low levels found in spleen, small intestine, lung, kidney and stomach.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C, and avoid repeat freeze-thaw cycles.
-
- Target
- CCL19 (Chemokine (C-C Motif) Ligand 19 (CCL19))
- Andere Bezeichnung
- MIP-3beta (CCL19 Produkte)
- Synonyme
- CKb11 antikoerper, ELC antikoerper, MIP-3b antikoerper, MIP3B antikoerper, SCYA19 antikoerper, CCL19 antikoerper, Scya19 antikoerper, exodus-3 antikoerper, C-C motif chemokine ligand 19 antikoerper, chemokine (C-C motif) ligand 19 antikoerper, CCL19 antikoerper, ccl19 antikoerper, Ccl19 antikoerper
- Molekulargewicht
- 10.993 kDa
- Gen-ID
- 6363
- UniProt
- Q99731
- Pathways
- Positive Regulation of Immune Effector Process
-